At the annual meeting of the American Society of Oncology (ASCO) held in Chicago in 2023, Chinese pharmaceutical enterprises submitted 44 abstracts that referred to solid tumors. Non-small cell lung cancer (NSCLC) was another topic that was addressed by a larger number of the submitted papers.
Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DXY.cn. (June 19, 2023). Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease [Graph]. In Statista. Retrieved January 07, 2025, from https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn. "Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease." Chart. June 19, 2023. Statista. Accessed January 07, 2025. https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn. (2023). Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease. Statista. Statista Inc.. Accessed: January 07, 2025. https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn. "Number of Clinical Research Papers Submitted by Chinese Pharmaceutical Enterprises at Asco 2023, by Addressed Disease." Statista, Statista Inc., 19 Jun 2023, https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn, Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease Statista, https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/ (last visited January 07, 2025)
Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease [Graph], DXY.cn, June 19, 2023. [Online]. Available: https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
